XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Mar. 31, 2020 $ 225 $ 64,649 $ 81,870 $ 2,099 $ 148,843
Balance (in shares) at Mar. 31, 2020 22,544,285        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     10,472   10,472
Cash dividend on common stock     (4,461)   (4,461)
Exercise of stock options $ 1 49     $ 50
Exercise of stock options (in shares) 20,000       20,000
Stock repurchased $ (3) (1,444)     $ (1,447)
Stock repurchased (in shares) (295,900)        
Restricted stock grants (in shares) 90,763        
Restricted stock forfeited (in shares) (7,913)        
Stock-based compensation expense   396     396
Other comprehensive income (loss), net       (2,259) (2,259)
Balance at Mar. 31, 2021 $ 223 63,650 87,881 (160) 151,594
Balance (in shares) at Mar. 31, 2021 22,351,235        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     21,820   21,820
Cash dividend on common stock     (4,769)   (4,769)
Exercise of stock options   17 (1)   $ 16
Exercise of stock options (in shares) 6,000       6,000
Stock repurchased $ (2) (1,938)     $ (1,940)
Stock repurchased (in shares) (278,148)        
Restricted stock grants (in shares) 69,285        
Restricted stock forfeited (in shares) (20,976)        
Stock-based compensation expense   319     319
Other comprehensive income (loss), net       (9,791) (9,791)
Balance at Mar. 31, 2022 $ 221 62,048 104,931 (9,951) 157,249
Balance (in shares) at Mar. 31, 2022 22,127,396        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     18,069   18,069
Cash dividend on common stock     (5,174)   (5,174)
Exercise of stock options   4     $ 4
Exercise of stock options (in shares) 1,511       1,511
Stock repurchased $ (9) (6,697)     $ (6,706)
Stock repurchased (in shares) (975,666)        
Restricted stock grants (in shares) 68,719        
Stock-based compensation expense   390     390
Purchase of subsidiary shares from noncontrolling interest   (234)     (234)
Other comprehensive income (loss), net       (8,359) (8,359)
Balance at Mar. 31, 2023 $ 212 $ 55,511 $ 117,826 $ (18,310) $ 155,239
Balance (in shares) at Mar. 31, 2023 21,221,960